VMI
CLCD

VHCP Management II’s CoLucid Pharmaceuticals, Inc. CLCD Stock Holding History

VHCP Management II’s Portfolio CLCD Stock Details CLCD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-159,110
Closed -$5.79M – 23
2016
Q4 		$5.79M Hold
159,110
– – 2.78% 9
2016
Q3 		$6.07M Buy
+159,110
New +$2.35M 3.12% 9

Other funds holding CLCD

FPF
FNY Partners Fund New York $185M AUM 32.57% 1-Year Est. Return

VHCP Management II's CLCD Position: Q1 2017 in Review

VHCP Management II sold out of CoLucid Pharmaceuticals, Inc. (CLCD) in Q1 2017, closing a stake of 159,110 shares — an estimated $5.79M sold.

VHCP Management II first reported a position in CLCD in Q3 2016 and held it in 2 quarters. The position peaked at $6.07M in Q3 2016. 1 fund tracked by Wall St. Rank holds CLCD as of Q1 2017.

  • VHCP Management II reported no remaining CoLucid Pharmaceuticals, Inc. position as of Q1 2017 after selling out during the quarter.
  • VHCP Management II sold 159,110 CoLucid Pharmaceuticals, Inc. shares in Q1 2017, an estimated $5.79M.
  • VHCP Management II first reported a position in CoLucid Pharmaceuticals, Inc. in Q3 2016 and held it in 2 quarters.
  • VHCP Management II's CoLucid Pharmaceuticals, Inc. position peaked at $6.07M in Q3 2016.
  • 1 fund tracked by Wall St. Rank held CoLucid Pharmaceuticals, Inc. as of Q1 2017.

Based on VHCP Management II's 13F filing for Q1 2017, filed 12 May 2017.